Sorafenib Tosylate
The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. [ ]
Term info
Sorafenib Tosylate
- 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic Acid Methyamide-4-methylbenzenesulfonate Tosylate
- BAY 43-9006 Tosylate
- BAY 54-9085
- Nexavar
- SORAFENIB TOSYLATE
- Sorafenib Tosylate
- sorafenib
- sorafenib tosylate
NCIT_C116978, NCIT_C63923, NCIT_C128784, NCIT_C116977, NCIT_C157711, NCIT_C157712
A drug used to treat advanced kidney cancer and a type of liver cancer that cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. Nexavar stops cells from dividing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of kinase inhibitor and a type of antiangiogenesis agent.
Advanced renal cell carcinoma; Metastatic Colorectal Cancer, Major Depressive Disorder
475207-59-1
CHEBI:50928
C21H16ClF3N4O3.C7H8O3S
CTRP, FDA
Sorafenib Tosylate
5T62Q3B36J
http://purl.obolibrary.org/obo/NCIT_C61948
http://purl.obolibrary.org/obo/NCIT_C17476, http://purl.obolibrary.org/obo/NCIT_C26202, http://purl.obolibrary.org/obo/NCIT_C17328, http://purl.obolibrary.org/obo/NCIT_C26203, http://purl.obolibrary.org/obo/NCIT_C30164, http://purl.obolibrary.org/obo/NCIT_C17484, http://purl.obolibrary.org/obo/NCIT_C28496
BAY_43-9006
724772
299013
299013
Sorafenib Tosylate
Pharmacologic Substance, Organic Chemical
C1676709
C2194
Term relations
- Raf Kinase Inhibitor
- Antineoplastic Enzyme Inhibitor
- VEGFR Tyrosine Kinase Inhibitor
- PDGFR Inhibitor
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition
- Chemical_Or_Drug_Has_Physiologic_Effect some Inhibition of Cell Proliferation
- Chemical_Or_Drug_Has_Physiologic_Effect some Signal Transduction Inhibition
- Chemical_Or_Drug_Has_Physiologic_Effect some Negative Regulation of Angiogenesis
- Chemical_Or_Drug_Affects_Gene_Product some RAF Proto-Oncogene Serine/Threonine-Protein Kinase